Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT (DM-COVER)
Primary Purpose
Coronary Heart Disease, Diabetes Mellitus
Status
Unknown status
Phase
Phase 4
Locations
China
Study Type
Interventional
Intervention
Polymer-based sirolimus-eluting stent(Cypher stent ) and Polymer-free paclitaxel-eluting stent (YinYi stent)
Sponsored by
About this trial
This is an interventional treatment trial for Coronary Heart Disease focused on measuring Optical coherence tomography, Drug eluting stent, Coronary heart disease, Diabetes mellitus
Eligibility Criteria
Inclusion Criteria:
General Inclusion Criteria:
- Age : 18-75Y
- Patients diagnosed as type 2 DM or non-DM.
Angiographic Inclusion Criteria:
- Patients were considered eligible if they have two significant (>70%) angiographic stenosis lesions in different native coronary vessels by CAG.
- Each target is de novo lesion that can be treated with 1-2 stents.
- Reference vessel diameter of 2.5 to 4.0 mm.
Exclusion Criteria:
General Exclusion Criteria:
- ST-segment elevation myocardial infarction within 7 days prior to the index procedure.
- Life expectancy <12 months due to another medical condition.
- Contraindication to antiplatelet therapy or a history of hypersensitivity to sirolimus and paclitaxel or structurally related compounds.
- Creatinine level more than 2.0mg/dL or ESRD.
- Severe hepatic dysfunction (more than 3 times normal reference values).
- Planned surgery procedure≤12 months post-index procedure.
- Known allergy to stainless steel.
- Female of childbearing potential with a positive pregnancy test within 7 days before the index procedure, or lactating, or intends to become pregnant during the 12 months post index procedure.
- Patient is not clinically appropriate for OCT evaluation in the opinion of investigator.
Angiographic Exclusion Criteria:
- Study lesion is ostial in location (within 3.0 mm of vessel origin).
- Study lesion involving arterial segments with highly tortuous anatomy.
- Complex lesion morphologies (bifurcation needs two stents technique, left main lesion, chronic obstructive occlusion, severe thrombus, heavy calcification).
Sites / Locations
- The second Affiliated Hospital of Harbin Medical UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Group A: DM
Group B: Non-DM
Arm Description
Coronary artery disease with diabetes mellitus
Coronary artery disease without diabetes mellitus
Outcomes
Primary Outcome Measures
Comparison of the surface coverage between DM and Non-DM at 6 months after Cypher and YINYI stent implantation using OCT.
Secondary Outcome Measures
Comparison of troponin-I levels between DM and Non-DM at baseline, 8 hours, 16 hours and 24 hours after stent implantation
Comparison of hsCRP concentration between DM and Non-DM at baseline, 8 hours, 16 hours and 24 hours after stent implantation
Comparison of the malapposition, neointimal heterogeneity and the incidence of thrombosis between DM and Non-DM patients after Cypher and YINYI implantation using OCT
Comparison of surface coverage, late stent malapposition, neointimal heterogeneity and the incidence of thrombosis between Cypher and YINYI in DM after stenting using OCT
Comparison of surface coverage, late stent malapposition, neointimal heterogeneity, and the incidence of thrombosis between Cypher and YINYI in Non-DM after stenting using OCT
QCA parameters and IVUS parameters for binary restenosis, late lumen loss.
Comparison of the surface coverage, late stent malapposition, neointimal heterogeneity, and the incidence of thrombosis between DM and Non-DM patients after Cypher and YINYI implantation using OCT
Comparison of surface coverage, late stent malapposition, neointimal heterogeneity, and the incidence of thrombosis between Cypher and YINYI in DM after stenting using OCT
Comparison of surface coverage, late stent malapposition, neointimal heterogeneity, and the incidence of thrombosis between Cypher and YINYI in Non-DM after stenting using OCT
QCA parameters and IVUS parameters for binary restenosis, late lumen loss.
TLR/TVR
MACE
Full Information
NCT ID
NCT01021930
First Posted
November 30, 2009
Last Updated
May 25, 2010
Sponsor
Harbin Medical University
1. Study Identification
Unique Protocol Identification Number
NCT01021930
Brief Title
Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT
Acronym
DM-COVER
Official Title
Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for Surface Coverage After Two Types of Drug-eluting Stent Implantation (A Pilot Study)
Study Type
Interventional
2. Study Status
Record Verification Date
December 2009
Overall Recruitment Status
Unknown status
Study Start Date
November 2009 (undefined)
Primary Completion Date
December 2010 (Anticipated)
Study Completion Date
June 2011 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Harbin Medical University
4. Oversight
5. Study Description
Brief Summary
Diabetic patients are prone to a diffuse and rapidly progressive form of atherosclerosis. Both clinical and angiographic outcomes following percutaneous coronary intervention (PCI) are poor in patients with DM compared with those without DM. Autopsy study has shown delayed neointimal healing with inadequate endothelialization and persistent stent surface fibrin deposition after DES implantation in DM patients. This might partially contribute to the high risk of late stent thrombosis.
YINYI Polymer-Free paclitaxel stent is a domestic new type stent with bare metal base with micro porous surface. However, limited data is available in vivo about the surface coverage after stent implantation in DM patients because of lack of sensitive imaging modalities. Optical coherence tomography (OCT) is an optical analogue of intravascular ultrasound(IVUS)that allows high-resolution tomographic intravascular imaging. Furthermore, several studies have demonstrated the feasibility of OCT to quantitatively evaluate the surface coverage and stent conditions in the follow up after PCI .
Therefore, the aim of this study was to analyze the surface coverage and late malapposition after two types of DES implantation in DM patients compared with non-DM patients by using OCT and IVUS.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Heart Disease, Diabetes Mellitus
Keywords
Optical coherence tomography, Drug eluting stent, Coronary heart disease, Diabetes mellitus
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
70 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Group A: DM
Arm Type
Active Comparator
Arm Description
Coronary artery disease with diabetes mellitus
Arm Title
Group B: Non-DM
Arm Type
Active Comparator
Arm Description
Coronary artery disease without diabetes mellitus
Intervention Type
Device
Intervention Name(s)
Polymer-based sirolimus-eluting stent(Cypher stent ) and Polymer-free paclitaxel-eluting stent (YinYi stent)
Intervention Description
Polymer-based sirolimus-eluting stent( Cypher, Cordis ) and Polymer-free paclitaxel-eluting stent (YinYi ),randomly implanted in two vessels of one patients
Primary Outcome Measure Information:
Title
Comparison of the surface coverage between DM and Non-DM at 6 months after Cypher and YINYI stent implantation using OCT.
Time Frame
6-month
Secondary Outcome Measure Information:
Title
Comparison of troponin-I levels between DM and Non-DM at baseline, 8 hours, 16 hours and 24 hours after stent implantation
Time Frame
at every 8-hour in first 24-hour after stent implantation
Title
Comparison of hsCRP concentration between DM and Non-DM at baseline, 8 hours, 16 hours and 24 hours after stent implantation
Time Frame
at every 8-hour in first 24-hour after stent implantation
Title
Comparison of the malapposition, neointimal heterogeneity and the incidence of thrombosis between DM and Non-DM patients after Cypher and YINYI implantation using OCT
Time Frame
6-month
Title
Comparison of surface coverage, late stent malapposition, neointimal heterogeneity and the incidence of thrombosis between Cypher and YINYI in DM after stenting using OCT
Time Frame
6-month
Title
Comparison of surface coverage, late stent malapposition, neointimal heterogeneity, and the incidence of thrombosis between Cypher and YINYI in Non-DM after stenting using OCT
Time Frame
6-month
Title
QCA parameters and IVUS parameters for binary restenosis, late lumen loss.
Time Frame
6-month
Title
Comparison of the surface coverage, late stent malapposition, neointimal heterogeneity, and the incidence of thrombosis between DM and Non-DM patients after Cypher and YINYI implantation using OCT
Time Frame
12-month
Title
Comparison of surface coverage, late stent malapposition, neointimal heterogeneity, and the incidence of thrombosis between Cypher and YINYI in DM after stenting using OCT
Time Frame
12-month
Title
Comparison of surface coverage, late stent malapposition, neointimal heterogeneity, and the incidence of thrombosis between Cypher and YINYI in Non-DM after stenting using OCT
Time Frame
12-month
Title
QCA parameters and IVUS parameters for binary restenosis, late lumen loss.
Time Frame
12-month
Title
TLR/TVR
Time Frame
12-month
Title
MACE
Time Frame
12-month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
General Inclusion Criteria:
Age : 18-75Y
Patients diagnosed as type 2 DM or non-DM.
Angiographic Inclusion Criteria:
Patients were considered eligible if they have two significant (>70%) angiographic stenosis lesions in different native coronary vessels by CAG.
Each target is de novo lesion that can be treated with 1-2 stents.
Reference vessel diameter of 2.5 to 4.0 mm.
Exclusion Criteria:
General Exclusion Criteria:
ST-segment elevation myocardial infarction within 7 days prior to the index procedure.
Life expectancy <12 months due to another medical condition.
Contraindication to antiplatelet therapy or a history of hypersensitivity to sirolimus and paclitaxel or structurally related compounds.
Creatinine level more than 2.0mg/dL or ESRD.
Severe hepatic dysfunction (more than 3 times normal reference values).
Planned surgery procedure≤12 months post-index procedure.
Known allergy to stainless steel.
Female of childbearing potential with a positive pregnancy test within 7 days before the index procedure, or lactating, or intends to become pregnant during the 12 months post index procedure.
Patient is not clinically appropriate for OCT evaluation in the opinion of investigator.
Angiographic Exclusion Criteria:
Study lesion is ostial in location (within 3.0 mm of vessel origin).
Study lesion involving arterial segments with highly tortuous anatomy.
Complex lesion morphologies (bifurcation needs two stents technique, left main lesion, chronic obstructive occlusion, severe thrombus, heavy calcification).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Bo Yu, MD,PhD
Phone
86-0451-86605180
Email
yubodr@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bo Yu, MD, PhD
Organizational Affiliation
The Second Affiliated Hospital of Harbin Medical University
Official's Role
Principal Investigator
Facility Information:
Facility Name
The second Affiliated Hospital of Harbin Medical University
City
Harbin
State/Province
Heilong jiang
ZIP/Postal Code
150081
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bo Yu, MD, PhD
Phone
86-0451-86605180
Email
yubodr@163.com
First Name & Middle Initial & Last Name & Degree
Bo Yu, MD.PhD
12. IPD Sharing Statement
Learn more about this trial
Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT
We'll reach out to this number within 24 hrs